Evidence map›Paper›PMID 41132660›Full record

ArticleFrontiers in immunology2025

Yuedong Xie, Guowen Lv, Dandan Su, Manchun Li, Quanle Xu, Hongbo Chen, Fang Cheng, Dongling Dai

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations.Clinical, cosmetic and investigational dermatology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuedong XieInternational Medical Center, Endoscopy Center and Gastroenterology Department, Shenzhen Children's Hospital, Shenzhen, China.
Guowen LvSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Dandan SuSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Manchun LiSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Quanle XuCollege of Life Sciences, Northwest A&F University, Yangling, China.
Hongbo ChenSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Fang ChengSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Dongling DaiInternational Medical Center, Endoscopy Center and Gastroenterology Department, Shenzhen Children's Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Current research underscores the critical role of the gut-skin axis in inflammatory skin disorders such as psoriasis, with growing interest in the therapeutic application of probiotics. Despite this promise, the specific mechanisms and bioactive compounds through which probiotics exert their effects remain poorly characterized. In this study, we aimed to systematically evaluate the therapeutic potential of Methods: The microbiome characteristics of psoriasis were analyzed through open microflora data mining and bibliometrics, and the probiotics with potential therapeutic effects were identified. Four bioactive fractions from Results: A common feature of downregulation of Discussion: This study demonstrates that

Indexed as

Anti-Inflammatory AgentsLactiplantibacillus plantarumProbioticsPsoriasisAnimalsDisease Models, AnimalHumansKeratinocytesMacrophagesMaleMiceSkinAnti-Inflammatory Agentsanandamidebacterial membrane vesiclesLactobacillus plantarumprecision microbiome therapypsoriasis

Identifiers

PMID41132660
PMCPMC12540108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.